hotspot -WSS

hotspot

author：hotspot 2025-09-30 23:40:51 - browse：25

A clipboard with checklist on blue dark background. -- health tech coverage from STAT — Adobe

A Pittsburgh artificial intelligence startup emerging as a challenger to Microsoft’s clinical note taking business has raised $150 million, a rare mega deal in a funding lull. The startup, Abridge, also has an unlikely cheerleader: Paul Ricci, the former head of Nuance, the service from Microsoft it competes with.

Abridge sells an AI tool that rapidly transcribes and summarizes doctors’ conversations with patients in a hospital’s electronic health records software. The startup’s leaders and investors tell STAT they’re betting that their medical knowledge, agility, and willingness to co-develop features with customers makes it a more attractive long term option than Nuance, which Microsoft says is currently used by most U.S. hospitals.

Microsoft, Abridge and other startups like Suki, Corti and Nabla are locked in a race to ease provider burnout by automating clinical note taking, and — thanks to generative AI — organizing the data in a way that could improve care, such as suggesting topics for follow-up, simplifying billing or analyzing trends at the broader patient population level.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Medicare Advantage overpayments discussion gets experts fired up

entertainment

WSS

Biotech lab space demand falls sharply

Boston Scientific acquires urology company Axonics for $3.7 billion

Allen Institute goes after foundational questions, CEO Costa says

Drug for rare kidney disease narrowly misses mark in clinical trial

Male doctors called my cancer incurable. A female doctor showed it wasn't

Lasker Awards 2023: Winners in biomedical research

explore

hotspot

leisure time

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Medicare Advantage coverage denials need scrutiny, senators say

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Study suggests new cause of Down syndrome: cells linked to aging

Hepatitis C has a cure — but many Americans still lack access to it

How Vertex's cystic fibrosis drug is changing patients' lives

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Virginia high school admissions case could be legal follow

Ukraine and a new approach to mental health in war

focus

Male doctors called my cancer incurable. A female doctor showed it wasn't

CDC advisers recommend seasonal use of Pfizer RSV shot

Hospital chaplains balance Covid safety with patients’ spiritual needs

It's been 20 years since Dolly the sheep. Where's my clone?

Senate HELP committee spars over health care workforce policies

Fauci's latest grilling in Congress: 9 hours, behind closed doors

explore

entertainment

focus

explore